← back to search

Upkar S. Gill

University College London · GB
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease Diagnosis and Treatment, and Immune Cell Function and Interaction.
h-index
31
citations
6,081
works
158
NIH funding
primary concept
Medicine
email

Recent publications

IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection
JCI Insight 2024cited by 21position: middledoi
Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS
Nature 2023cited by 72position: middledoi
Evaluation of the HBV liver reservoir with fine needle aspirates
JHEP Reports 2023cited by 18position: middledoi
The human liver microenvironment shapes the homing and function of CD4 <sup>+</sup> T-cell populations
Gut 2021cited by 49position: middledoi
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
Journal of Hepatology 2020cited by 525position: middledoi
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
Journal of Hepatology 2020cited by 270position: middledoi
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection
Gastroenterology 2020cited by 190position: middledoi
Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B
Journal of Hepatology 2019cited by 95position: middledoi
PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection
Journal of Clinical Investigation 2018cited by 280position: middledoi
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
Gastroenterology 2016cited by 475position: middledoi
Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B
Gastroenterology 2012cited by 319position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Patrick Kennedy · University of Melbourne6 papers (2012–2023)Antonio Bertoletti · Duke-NUS Medical School5 papers (2012–2020)Nina Le Bert · Duke-NUS Medical School3 papers (2018–2020)Charles‐Antoine Dutertre · Inserm3 papers (2018–2020)Anthony T. Tan · Global Strategy Group3 papers (2012–2020)Magdeleine Hung · Gilead Sciences (United States)2 papers (2018–2019)Nikolai Novikov · Gilead Sciences (United States)2 papers (2018–2019)Michelle Hong · University of Toronto2 papers (2016–2020) · 2 papers (2012–2016)Loghman Salimzadeh · National University of Singapore2 papers (2018–2019)Simon P. Fletcher · Gilead Sciences (United States)2 papers (2018–2019)Evan W. Newell · Fred Hutch Cancer Center2 papers (2018–2020) · 1 papers (2020–2020) · 1 papers (2021–2021)Fabien Zoulim · Inserm1 papers (2023–2023)Massimo Levrero · Physiopathologie et Epidémiologie des Maladies Respiratoires1 papers (2023–2023)Graham R. Foster · Queen Mary University of London1 papers (2012–2012)Konstantinos Aliazis · University of Birmingham1 papers (2021–2021)Juandy Jo · Utrecht University1 papers (2012–2012)Tu Vinh Luong · Royal Free London NHS Foundation Trust1 papers (2021–2021)